Acetylcarnitine and Insulin Sensitivity
NCT00393770
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
43
Enrollment
OTHER
Sponsor class
Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG:
L-acetylcarnitine
Sponsor
Mario Negri Institute for Pharmacological Research